Lab-on-a-chip (LOC) devices are miniaturized platforms that integrate multiple laboratory functions onto a single chip. These devices are used in various applications, including diagnostics, genomics, proteomics, and drug discovery. Companies specializing in lab-on-a-chip devices play a crucial role in developing and advancing these microfluidic technologies.
Cellairis Biomarkers Signed a collaboration agreement with AstraZeneca to develop and commercialize LOC-based assays for biomarker discovery and validation in oncology research.
Dolomite Microfluidics Launched the µFLUX Prime™ microfluidic workstation, offering a flexible and user-friendly platform for rapid prototyping and development of LOCs.
Emulate Expanded its Organ-on-a-Chip technology platform with the launch of the Emulate Lung-Chipâ„¢ model, providing researchers with a realistic model to study lung diseases and drug responses.
Abbott Laboratories Received FDA approval for its i-STAT Alinity CL system, featuring LOC technology for rapid blood gas and electrolyte testing in point-of-care settings.
Roche Diagnostics Introduced the cobas® EGFR Mutation Test on its cobas® m500 system, utilizing LOC technology for rapid and efficient detection of EGFR mutations in cancer patients.
List of Lab-on-a-Chip Device Key Companies in the Market
Lab-on-a-Chip Device Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)